A groundbreaking study has illuminated a potential link between a prevalent bacterial species, commonly associated with respiratory ailments like pneumonia and sinus infections, and the progression of Alzheimer’s disease. Researchers from Cedars-Sinai have presented compelling evidence indicating that Chlamydia pneumoniae, a microorganism known for its persistence, can remain dormant within ocular and neural tissues for extended periods. The presence of this bacterium, the study posits, may significantly contribute to the pathological damage characteristic of Alzheimer’s. These pivotal findings, detailed in the esteemed journal Nature Communications, open promising avenues for novel therapeutic strategies, potentially involving the early intervention of chronic infections and inflammation through antibiotic regimens or anti-inflammatory agents.
For the first time, this research provides definitive proof that Chlamydia pneumoniae can establish a presence in the retina, the light-sensitive membrane lining the back of the eye. Upon infiltration, the bacterium appears to trigger robust immune responses. These responses, characterized by inflammation, are intrinsically linked to the degeneration of nerve cells and a subsequent decline in cognitive capabilities. Dr. Maya Koronyo-Hamaoui, a distinguished professor of Neurosurgery, Neurology, and Biomedical Sciences at Cedars-Sinai Health Sciences University and the senior author of the investigation, emphasized the significance of this discovery. "Observing Chlamydia pneumoniae consistently across diverse biological samples – human tissues, laboratory cell cultures, and animal models – has enabled us to pinpoint a previously unrecognized connection between bacterial infection, the body’s inflammatory responses, and the deterioration of neural tissue," Dr. Koronyo-Hamaoui stated. She further elaborated on the diagnostic implications, noting, "The eye serves as a remarkable proxy for the brain. This study unequivocally demonstrates that bacterial infections within the retina and the resultant chronic inflammation can mirror the pathological changes occurring in the brain and accurately predict an individual’s disease status. Consequently, retinal imaging emerges as a valuable non-invasive method for identifying individuals at heightened risk for Alzheimer’s disease."
The investigative team meticulously examined retinal tissue samples obtained from 104 participants, employing sophisticated imaging techniques, advanced genetic analyses, and detailed protein profiling. The cohort comprised individuals exhibiting a spectrum of cognitive health, including those with normal cognitive function, mild cognitive impairment, and diagnosed Alzheimer’s disease. The analysis revealed a stark contrast: individuals with Alzheimer’s disease exhibited substantially higher concentrations of Chlamydia pneumoniae in both their retinas and brains when compared with their cognitively healthy counterparts. Furthermore, the research established a clear correlation between the abundance of this bacterium and the severity of observed brain damage, as well as the degree of cognitive decline experienced by the participants. This association was particularly pronounced in individuals who carried the APOE4 gene variant, a well-established genetic factor known to elevate the risk of developing Alzheimer’s disease.
To rigorously validate the observed association, the scientists undertook a series of experiments. These involved cultivating human nerve cells in laboratory settings and studying the pathological progression in mice models engineered to exhibit Alzheimer’s-like symptoms. In both experimental paradigms, exposure to Chlamydia pneumoniae infection resulted in amplified inflammatory markers, increased neuronal cell death, and a discernible worsening of cognitive deficits. Crucially, the bacterial infection also appeared to stimulate the overproduction of amyloid-beta, a key protein implicated in the formation of the characteristic plaques found in the brains of individuals with Alzheimer’s disease.
The research was co-led by Bhakta Gaire, PhD, and Yosef Koronyo, MSc, who served as co-first authors. Dr. Timothy Crother, a co-corresponding author of the study and a research professor at Cedars-Sinai Guerin Children’s and the Department of Biomedical Sciences, highlighted the therapeutic potential of these findings. "This discovery opens up the compelling possibility of targeting the intricate interplay between infection and inflammation as a novel therapeutic strategy for Alzheimer’s disease," Dr. Crother remarked.
Collectively, the study’s findings strongly suggest that interventions aimed at eradicating long-standing bacterial infections and mitigating the chronic inflammation they instigate could represent a paradigm shift in the treatment of Alzheimer’s disease. Moreover, the research reinforces the utility of the retina as a non-invasive diagnostic tool, offering a promising method for the early detection and ongoing monitoring of Alzheimer’s disease progression. The comprehensive list of contributing authors from Cedars-Sinai includes Bhakta Gaire, Yosef Koronyo, Jean-Philippe Vit, Alexandre Hutton, Lalita Subedi, Dieu-Trang Fuchs, Natalie Swerdlow, Altan Rentsendorj, Saba Shahin, Daisy Martinon, Edward Robinson, Alexander V. Ljubimov, Keith L. Black, Jesse Meyer, and Moshe Arditi. Additional contributions were made by Julie A. Schneider, Lon S. Schneider, Debra Hawes, Stuart L. Graham, Vivek K. Gupta, and Mehdi Mirzaei. This extensive body of work was made possible through significant financial support from the National Institutes of Health/National Institute on Aging (NIH/NIA) under grant numbers R01AG056478, R01AG055865, and AG056478-04S1 (awarded to M.K.H.), R01AG075998 (awarded to M.K.H. and T.R.C.), and an Alzheimer’s Association grant AARG-NTF-21-846586 (awarded to T.R.C.). M.K.H. also received support from The Goldrich and Snyder Foundations, and E.R. was supported by The Ray Charles Foundation.
About the Author
